Načítá se...
The antibiotic drug tigecycline: A focus on its promising anticancer properties
Tigecycline (TIG), the first member of glycylcycline bacteriostatic agents, has been approved to treat complicated infections in the clinic because of its expanded-spectrum antibiotic potential. Recently, an increasing number of studies have emphasized the anti-tumor effects of TIG. The inhibitory e...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2016-12-01
|
| Edice: | Frontiers in Pharmacology |
| Témata: | |
| On-line přístup: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00473/full |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|